BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leuschner M, Holtmeier J, Ackermann H, Leuschner U. The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study. Eur J Gastroenterol Hepatol. 2002;14:1369-1376. [PMID: 12468960 DOI: 10.1097/00042737-200212000-00014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Hofmann AF, Zakko SF, Lira M, Clerici C, Hagey LR, Lambert KK, Steinbach JH, Schteingart CD, Olinga P, Groothuis GM. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology. 2005;42:1391-1398. [PMID: 16317695 DOI: 10.1002/hep.20943] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
2 Trauner M, Fickert P, Halilbasic E, Moustafa T. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. Wien Med Wochenschr. 2008;158:542-548. [PMID: 18998069 DOI: 10.1007/s10354-008-0592-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 6.1] [Reference Citation Analysis]
3 Trauner M, Fuchs CD, Halilbasic E, Paumgartner G. New therapeutic concepts in bile acid transport and signaling for management of cholestasis. Hepatology 2017;65:1393-404. [PMID: 27997980 DOI: 10.1002/hep.28991] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 23.5] [Reference Citation Analysis]
4 Strassburg CP, Manns MP. [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy]. Internist (Berl) 2004;45:16-26. [PMID: 14735240 DOI: 10.1007/s00108-003-1127-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mayo MJ. Primary biliary cirrhosis: the future. Clin Liver Dis. 2003;7:957-969. [PMID: 14594140 DOI: 10.1016/s1089-3261(03)00093-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DEJ, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: Report of a focus study group. Hepatology 2004;40:1013-20. [DOI: 10.1002/hep.1840400434] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
7 Trauner M, Boyer JL. Cholestatic syndromes: . Current Opinion in Gastroenterology 2003;19:216-31. [DOI: 10.1097/00001574-200305000-00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
8 Silveira MG, Lindor KD. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. Clin Liver Dis. 2008;12:425-443; x-xi. [PMID: 18456189 DOI: 10.1016/j.cld.2008.02.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
9 Yokoda RT, Carey EJ. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Am J Gastroenterol 2019;114:1593-605. [PMID: 31169523 DOI: 10.14309/ajg.0000000000000268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
10 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237-267. [PMID: 19501929 DOI: 10.1016/j.jhep.2009.04.009] [Cited by in Crossref: 1087] [Cited by in F6Publishing: 948] [Article Influence: 90.6] [Reference Citation Analysis]
11 Reshetnyak VI. Concept on the pathogenesis and treatment of primary biliary cirrhosis. World J Gastroenterol 2006; 12(45): 7250-7262 [PMID: 17143938 DOI: 10.3748/wjg.v12.i45.7250] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
12 Oo YH, Neuberger J. Options for treatment of primary biliary cirrhosis. Drugs 2004;64:2261-71. [PMID: 15456326 DOI: 10.2165/00003495-200464200-00001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]